Management Team

Dr. Andrew Sweet

Director of Regulatory Affairs / Quality Assurance

API Manufacturing and cGMP Polymer Manufacturing

Dr.  Sweet started his career with PCI Synthesis in 1999.

He develops, manages and directs all of the Company’s efforts for implementing a cGMP quality system.   Andy also oversees the Company’s regulatory strategy and submissions to FDA and international regulatory bodies.

He previously held multiple positions within the Manufacturing, R&D and Quality groups of ChemDesign Corporation

Andy earned degrees from Gordon College (BA) and the University of Massachusetts, Amherst (MA, PhD ABD)